Search Results - "renal cell carcinoma"

NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways by Bihui Li, Bihui Li, Xing Zhang, Qianyao Ren, Li Gao, Jing Tian

Connect to this object online.

Prostatic adenocarcinoma (PCa) metastasizing to renal cell carcinoma (RCC) with periureteral tumor deposit: A case of tumor-to-tumor metastasis (TTM) by Jenissa Amor Dionisio Arceño, MD, Jonathan Salcedo Mendoza, MD, Josefino Cortez Castillo, MD, Jeffrey Santos So, MD

Connect to this object online.

Are acquired cystic kidney disease and autosomal dominant polycystic kidney disease risk factors for renal cell carcinoma in kidney transplant patients? by Behzad Einollahi

Connect to this object online.

Synchronous clear cell renal cell carcinoma and tubulocystic carcinoma: genetic evidence of independent ontogenesis and implications of chromosomal imbalances in tumor progression by Quiroga-Garza Gabriela, Piña-Oviedo Sergio, Cuevas-Ocampo Karime, Goldfarb Richard, Schwartz Mary R, Ayala Alberto G, Monzon Federico A

Connect to this object online.

Case report: successful response to bevacizumab combined with erlotinib for a novel FH gene mutation hereditary leiomyoma and renal cell carcinoma by Xiaoming Bai, Dan Xiang, Mengxi Huang, Yitian Chen, Yitian Chen

Connect to this object online.

Identifying an Immune-Related Gene ST8SIA1 as a Novel Target in Patients With Clear-Cell Renal Cell Carcinoma by Xu Hu, Yanfei Yang, Yaohui Wang, Shangqing Ren, Shangqing Ren, Xiang Li

Connect to this object online.

Multicentric papillary and chromophobe renal cell carcinomas in a patient with autosomal dominant polycystic kidney disease: Report of a rare case by Nibedita Sahoo, Susama Patra, Swagatika Senapati, Tushar S Mishra

Connect to this object online.

Altered cytoplasmic and nuclear ADP‐ribosylation levels analyzed with an improved ADP‐ribose binder are a prognostic factor in renal cell carcinoma by Peter Schraml, Fabio Aimi, Martin Zoche, Domingo Aguilera‐Garcia, Fabian Arnold, Holger Moch, Michael O Hottiger

Connect to this object online.

Belzutifan, HIF-2α Inhibitor, and Clear Cell Renal Cell Carcinoma With Somatic Von-Hippel-Lindau Loss-of-Function Mutation by Kok Hoe Chan MD, Ningjing Li MD, Ran Lador MD, Mark Amsbaugh MD, Anneliese Gonzalez MD, Putao Cen MD

Connect to this object online.

Targeting the Adenosine A2A Receptor as a Novel Therapeutic Approach for Renal Cell Carcinoma: Mechanisms and Clinical Trial Review by Ting-Yu Chen, Ya-Chuan Chang, Chia-Ying Yu, Wen-Wei Sung

Connect to this object online.

Cost-Effectiveness of Nivolumab Plus Cabozantinib Versus Sunitinib as a First-Line Treatment for Advanced Renal Cell Carcinoma in the United States by SiNi Li, SiNi Li, SiNi Li, JianHe Li, LiuBao Peng, YaMin Li, YaMin Li, XiaoMin Wan

Connect to this object online.

Diagnostic utility of amylase α-1A, MOC 31, and CD 82 in renal oncocytoma versus chromophobe renal cell carcinoma by Nehal S Abouhashem, Eman H Abdelbary, Mohamed M H. Abdalla, Mohamed El-Shazly

Connect to this object online.

Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model by Robin I. J. Merkx, Mark Rijpkema, Gerben M. Franssen, Annemarie Kip, Bart Smeets, Alfred Morgenstern, Frank Bruchertseifer, Eddie Yan, Michael P. Wheatcroft, Egbert Oosterwijk, Peter F. A. Mulders, Sandra Heskamp

Connect to this object online.

Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma by Shi-Yao Wei, Bei Feng, Min Bi, Hai-Ying Guo, Shang-Wei Ning, Rui Cui

Connect to this object online.

Cost-effectiveness comparison of cabozantinib with everolimus, axitinib, and nivolumab in the treatment of advanced renal cell carcinoma following the failure of prior therapy in England by Meng J, Lister J, Vataire AL, Casciano R, Dinet J

Connect to this object online.

Emerging Biomarkers in Personalized Therapy of Urologic Tumors

Subjects: “…Renal cell carcinoma…”
DOAB: download the publication
DOAB: description of the publication

MicroRNA-204-5p hampers the malignant progression of clear cell renal cell carcinoma through GXYLT2 down-regulation by Ying Wu, Qin Liao

Connect to this object online.

RETRACTED: Case report: A rare case of tumor-to-tumor metastasis: metastatic lobular breast carcinoma to clear cell renal cell carcinoma by Letian Zhang, Pei Yuan, Qi Cao, Jiali Mu, Jianming Ying, Changyuan Guo

Connect to this object online.

MicroRNA-155-5p targets NR3C2 to promote malignant progression of clear cell renal cell carcinoma by Chengquan Yan, Pengfei Wang, Chaofei Zhao, Guangwei Yin, Xin Meng, Lin Li, Shengyong Cai, Bin Meng

Connect to this object online.

Muscle mass change using linear measurement analysis after nephrectomy for pT3 and pT4 renal cell carcinoma is associated with mortality by Alexandra Medline, Eric Midenberg, Dattatraya Patil, Sean Evans, Nikhil Vettikattu, Fatima Kamal, Kenneth Ogan, Sarah P. Psutka, Mehmet Asim Bilen, Viraj A. Master

Connect to this object online.